Lorcaserin Weight Management APD791 Arterial Thrombosis APD916 Narcolepsy and Cataplexy APD811 Pulmonary Arterial Hypertension APD597 Type 2 Diabetes Research Programs Cardiovascular Central Nervous System Inflammatory Diseases Metabolic Diseases

Our product candidates have not been approved by the U.S. Food and Drug Administration or any international regulatory agency.

(This page was last updated: January 5, 2010. Additional information regarding Arena is available in its SEC filings.)

Back To Top